Skip to content

The Efficacy and Safety of Thunderbeat in Thyroid Surgery

The Efficacy and Safety of Thunderbeat in Thyroid Surgery: a Prospective Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02304172
Acronym
Thunderbeat
Enrollment
50
Registered
2014-12-01
Start date
2014-11-30
Completion date
2016-02-29
Last updated
2016-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid

Keywords

Thyroidectomy, Thunderbeat

Brief summary

The aim of this study is to compare the results of total thyroidectomy using the Thunderbeat device to that with the harmonic scalpel.

Detailed description

Thunderbeat instrument combines an advanced bipolar clamp to the existing ultrasonic cutter. In the animal study with pig, the result of Thunderbeat shows fast abalation rate and same thermal conductivity. There has been reported a significant reduction in operative time and same complications with Thunderbeat in gynecology patient who underwent laparoscopic hysterectomy with lymph node dissection. Comparison of the utilization of this new device, however, with the Harmonic scalpel in thyroidectomy has not been performed in any study. The objective of this study is to compare the results of thyroidectomy using the Thunderbeat to that with the Harmonic scalpel device in respect to hemostasis, operative time and perioperative complications. All patients undergoing a thyroidectomy in our endocrine surgery department are randomized into those operated with Thunderbeat (Group A) and those with Harmonic scalpel (Group B).

Interventions

DEVICEThunderbeat (Group A)

hemostatic device utilized intraoperatively

DEVICEHarmonic (Group B)

hemostatic device utilized intraoperatively

Sponsors

Olympus Korea Co., Ltd.
CollaboratorUNKNOWN
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* thyroidectomy * normal vocal cord

Exclusion criteria

* additional surgical procedures together with the total thyroidectomy (i.e., parathyroidectomy or cervical lymph node dissection) * Thyroid cancer patients with lymph node metastasis * pregnant women * uncontrolled hypertension, DM, chronic kidney failure, coagulation disorders * aspirin or anti-platelet agent in 7 days * Graves' disease or Hashimoto thyroiditis * history of radiation treatment in head and neck area

Design outcomes

Primary

MeasureTime frame
Postoperative complications including laryngeal nerve palsy, hypocalcemia, hemorrhage, hematoma, wound infection and skin burnpostoperatively (from the day of surgery until 3 months postoperatively)

Secondary

MeasureTime frame
Hemostasisintraoperatively (from skin incision to skin closure) & postoperatively (from skin closure until 2 day postoperatively)
Operative timefrom skin incision to skin closure

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026